This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Investigations in hyperthyroidism

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Thyroid function tests consist of:

  • serum TSH -
    • has the highest sensitivity and specificity for hyperthyroidism
    • is the initial investigations in majority of patients with suspected thyrotoxicosis (if thyrotoxicosis is strongly suspected, serum TSH, free T4, and total T3 are assessed at the initial evaluation) (1,2)
    • levels of TSH are low and normal concentration nearly always excludes the diagnosis of thyrotoxicosis; the rare exceptions to this are a TSH-producing pituitary tumour or thyroid hormone resistance syndrome.
  • free thyroxine (T4) & free or total triiodothyronine (T3)

In addition the following investigations can be carried out:

  • serum levels of antibodies to the TSH receptor
    • useful to establish the diagnosis of Graves disease (especially when a radionuclide thyroid scan cannot be performed)
    • antibodies measured with immunoassay method (3rd generation) has a sensitivity of 98% and a specificity of 99% for diagnosis of Graves’ disease
  • thyroid peroxidase and thyroglobulin autoantibodies
    • thyroid peroxidase antibodies are present only in about 75% of cases of Graves’ disease
  • radioactive iodine uptake and scan
    • uptake is the percentage of an iodine 123 (I-123) tracer dose taken up by the thyroid gland, ranging from 15% to 25% at 24 hours.
    • uptake is very low (0% to 2%) in thyroiditis while it is high in Graves disease, a toxic adenoma, or a toxic multinodular goitre
  • thyroid ultrasound scan
    • useful as a cost effective and safe alternative for radioactive scan
    • useful during pregnancy, lactation, and in amiodarone-induced thyrotoxicosis (1,2,3)

Other investigations:

  • FBC:
    • normochromic normocytic anaemia may be seen in Graves' disease
  • ESR:
    • raised in Graves' disease
    • high in subacute thyroiditis
  • calcium - often raised
  • LFTs - may be abnormal in Graves' disease (4)

Reference:

  1. Ross DS et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421
  2. Kravets I. Hyperthyroidism: Diagnosis and Treatment. Am Fam Physician. 2016;93(5):363-70.
  3. Vaidya B, Pearce SH. Diagnosis and management of thyrotoxicosis. BMJ. 2014;349:g5128
  4. Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European Thyroid Association Guideline for the management of Graves' hyperthyroidism. Eur Thyroid J. 2018 Jul 25;7(4):167-86.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.